These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 9407216)
21. Liability issues with the Papanicolaou smear: a defense lawyer's perspective. Varner CD Arch Pathol Lab Med; 1997 Mar; 121(3):315-20. PubMed ID: 9111126 [No Abstract] [Full Text] [Related]
22. Sensitivity of primary screening by rapid review: 'to act or not to act on the results, that is the question'. Slater DN Cytopathology; 1998 Apr; 9(2):77-83. PubMed ID: 9577733 [No Abstract] [Full Text] [Related]
23. Papanicolaou Society of Cytopathology guidelines for educational notes, disclaimers, and similar comments on reports of cervical cytology specimens. Papanicolau Society of Cytopathology Practice Guidelines Task Force Diagn Cytopathol; 2003 May; 28(5):282-5. PubMed ID: 12722126 [TBL] [Abstract][Full Text] [Related]
24. How preventable is invasive cervical cancer? A community study of preventable factors. Martin PL Trans Pac Coast Obstet Gynecol Soc; 1971; 39(0):114-21. PubMed ID: 5164820 [No Abstract] [Full Text] [Related]
25. [Factors which affect cytodiagnosis in gynecology]. Kobilková J; Lojda Z; Dusková J; Beková A Cesk Patol; 2001 Jan; 37(1):10-4. PubMed ID: 11268699 [TBL] [Abstract][Full Text] [Related]
26. Déjà vu in pap testing: return of the 5% false-negative fraction and the zero-error rate. Renshaw AA Diagn Cytopathol; 2002 Jun; 26(6):343-4. PubMed ID: 12112821 [No Abstract] [Full Text] [Related]
27. How preventable is invasive cervical cancer? A community study of preventable factors. Martin PL Am J Obstet Gynecol; 1972 Jun; 113(4):541-8. PubMed ID: 4636632 [No Abstract] [Full Text] [Related]
29. Cervical cytology: perspectives from both sides of the Atlantic. Bonfiglio TA Hum Pathol; 1997 Feb; 28(2):117-9. PubMed ID: 9023389 [No Abstract] [Full Text] [Related]
30. Effect of circulation and discussion of cervical smears on agreement between laboratories. Ronco G; Montanari G; Confortini M; Parisio F; Berardengo E; Delpiano AM; Arnaud S; Campione D; Baldini D; Poll P; Lynge E; Mancini E; Segnan N Cytopathology; 2003 Jun; 14(3):115-20. PubMed ID: 12828719 [TBL] [Abstract][Full Text] [Related]
36. Challenges in cervical cancer screening: what clinicians, patients and the general public need to know. Grohs DH Acta Cytol; 1996; 40(1):133-7. PubMed ID: 8604566 [No Abstract] [Full Text] [Related]
38. Pitfalls in the screening and early diagnosis of cervical cancer. Wain GV; Hacker NF Curr Opin Obstet Gynecol; 1990 Feb; 2(1):74-9. PubMed ID: 2102310 [No Abstract] [Full Text] [Related]
39. Anticipating the impact of the new screening guidelines on cytology and molecular laboratories. Booth CN Cancer Cytopathol; 2013 May; 121(5):225-7. PubMed ID: 23281254 [No Abstract] [Full Text] [Related]